Spectrum Health Immunochemistry Laboratory is pleased to announce 5 new allergen tests and the addition of Tryptase. The following allergens are now available:
Emergency Medicine
Obsoletion of Mayo Send-Out Test Influenza Virus A/B Antibodies, IgG and IgM
As of October 29, 2020, the following send-out tests will be will become obsoleted due to lack of clinical utility:
♦ SFLA Influenza Virus A Antibodies, IgG and IgM (Separate Determinations), Serum [LAB802]
♦ SFLB Influenza Virus B Antibodies, IgG and IgM (Separate Determinations), Serum [LAB803]
For diagnosis of acute Influenza infection the following molecular tests are recommended:
♦ Influenza A/B Rapid [LAB9240]**
♦ Influenza A/B Rapid, Influenza A/B PCR if Negative [LAB2111530]**
**Available only at regionals and during times of high flu incidence
REMINDER: Herpes Simplex Virus (HSV) PCR and HSV Culture Orders
Please refer to the below for Herpes Simplex Virus (HSV) orders:
Influenza Testing Reminder (2019 – 2020 Flu Season)
At this time when Influenza prevalence is not widespread in the community, please order “Influenza A/B PCR” [LAB3255] when testing is needed. This applies to patients at all Grand Rapids and regional hospitals, and also system wide ambulatory patients.
Effective March 4th, 2020, Thrombin Time will change from a sendout reference test performed by Mayo Clinic Laboratories to an in-house test performed by Spectrum Health Regional Laboratory. This test will be performed in the Coagulation Laboratory and will include a new reference range (please see link in Test Information below).
Thrombin Time is suitable for monitoring fibrinolysis therapy, screening for disorders of fibrin formation and in cases of suspected fibrinogen deficiency states. It is also useful for the differentiation between a heparin induced prolongation of the thrombin time and fibrin formation disorders.
For questions around this test, please contact the Coagulation Department at 616-267-2740.
TEST INFORMATION
Thrombin Time – Epic Code: #LAB11230581, Interface Code: #11230581, CPT: #85670
Effective Wednesday, November 13, 2019, the new Mycoplasma genitalium (mgen) assay is now available using the Aptima target nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium to aid in the diagnosis of M. genitalium urogenital infections in male and female patients.